Cardlytics (NASDAQ:CDLX) Announces Earnings Results, Beats Estimates By $0.18 EPS

Cardlytics (NASDAQ:CDLXGet Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.15) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.33) by $0.18, Briefing.com reports. Cardlytics had a negative return on equity of 93.64% and a negative net margin of 93.55%. The firm had revenue of $67.06 million for the quarter, compared to the consensus estimate of $57.77 million. During the same quarter in the previous year, the company earned ($0.26) EPS. The business’s revenue for the quarter was down 15.1% compared to the same quarter last year. Cardlytics updated its Q4 2024 guidance to EPS.

Cardlytics Price Performance

Shares of CDLX traded up $0.30 during trading hours on Friday, reaching $4.37. 1,752,101 shares of the stock traded hands, compared to its average volume of 726,140. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 1.01. Cardlytics has a 52-week low of $2.89 and a 52-week high of $20.52. The company’s 50-day moving average price is $3.69 and its two-hundred day moving average price is $6.70. The company has a market cap of $222.09 million, a P/E ratio of -0.72 and a beta of 1.61.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on CDLX shares. Northland Capmk cut Cardlytics from a “strong-buy” rating to a “hold” rating in a report on Friday, August 16th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cardlytics in a research note on Thursday. Northland Securities cut Cardlytics from an “outperform” rating to a “market perform” rating and cut their target price for the company from $7.00 to $5.00 in a research note on Friday, August 16th. Craig Hallum raised Cardlytics from a “hold” rating to a “strong-buy” rating in a report on Wednesday. Finally, Evercore ISI initiated coverage on shares of Cardlytics in a research note on Friday, October 11th. They set an “in-line” rating and a $4.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Cardlytics presently has an average rating of “Hold” and a consensus price target of $6.92.

Check Out Our Latest Stock Report on CDLX

Insider Activity

In other Cardlytics news, CEO Amit Gupta sold 22,607 shares of the business’s stock in a transaction on Thursday, October 24th. The shares were sold at an average price of $3.85, for a total transaction of $87,036.95. Following the transaction, the chief executive officer now owns 178,519 shares in the company, valued at $687,298.15. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other news, Director Scott A. Hill bought 40,000 shares of the company’s stock in a transaction that occurred on Monday, August 12th. The shares were purchased at an average price of $3.58 per share, for a total transaction of $143,200.00. Following the completion of the transaction, the director now directly owns 40,000 shares in the company, valued at approximately $143,200. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Amit Gupta sold 22,607 shares of the business’s stock in a transaction on Thursday, October 24th. The shares were sold at an average price of $3.85, for a total transaction of $87,036.95. Following the completion of the transaction, the chief executive officer now owns 178,519 shares of the company’s stock, valued at approximately $687,298.15. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 43,573 shares of company stock worth $151,612 over the last 90 days. Corporate insiders own 4.40% of the company’s stock.

Cardlytics Company Profile

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Featured Articles

Earnings History for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.